Open Access
Subscription or Fee Access
THE CASE FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN AFRICA
Abstract
While venous thromboembolism (VTE) is a well recognised occurrence in clinical
practice in the developed world, with event rates of at least 2-3 million per year, little
attention is paid to this entity in the developing world where the burden of infectious
diseases and limited access to care have not recognised VTE as a significant cause of
morbidity and mortality. The opportunity for Africa to do better as the inevitable
recognition of the consequence of VTE becomes more apparent is available using
basic tools and therapies.
practice in the developed world, with event rates of at least 2-3 million per year, little
attention is paid to this entity in the developing world where the burden of infectious
diseases and limited access to care have not recognised VTE as a significant cause of
morbidity and mortality. The opportunity for Africa to do better as the inevitable
recognition of the consequence of VTE becomes more apparent is available using
basic tools and therapies.
Refbacks
- There are currently no refbacks.
